Stay up to date with the latest news about our innovation initiatives

More than 450 scientists subscribed and over 170 different proposals received.

Partnership between Almirall, S.A. and Barcelona Supercomputing Center to identify novel targets to treat dermatological diseases.

SilicoDerm computational methodologies will facilitate the identification of active compounds for the treatment of inflammatory skin diseases.

Almirall S.A. and Evotec AG have entered into a research collaboration to develop first-in-class therapies for debilitating dermatology diseases.